Skip to main content

Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.